Does Adding Zevalin® to Reduced Intensity Regimen (RIC) of Fludarabine and Melphalan Improve Outcome of Patients with Relapsed/Refractory B-Cell Lymphoma Who Were Chemoresistant and FDG PET Positive at the Time of Allo-HCT?

Authors :: Andrew Raubitschek
Ji-Lian Cai
Firoozeh Sahebi
Auayporn Nademanee
Jennifer Simpson
Leslie Popplewell
Joycelynne Palmer
Tracey Stiller
Robert T. Chen
Stephen J. Forman
Source :: Biology of Blood and Marrow Transplantation. 22:S341-S342
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Melphalan
Transplantation
medicine.medical_specialty
business.industry
Reduced intensity
Hematology
medicine.disease
Surgery
Fludarabine
Regimen
Internal medicine
Relapsed refractory
medicine
business
B-cell lymphoma
medicine.drug

Full Text Access

Tools